Trial Profile
Ropinirole in early Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 05 Nov 2010 New trial record.